CCM

Catalio Capital Management Portfolio holdings

AUM $566M
1-Year Est. Return 106.72%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+106.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$566M
AUM Growth
+$24.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
52
New
Increased
Reduced
Closed

Top Buys

1
+$35.2M
2
+$31.2M
3
+$23.9M
4
EW icon
Edwards Lifesciences
EW
+$15.4M
5
MLYS icon
Mineralys Therapeutics
MLYS
+$13.3M

Top Sells

1
+$35.9M
2
+$32.3M
3
+$30.1M
4
ISRG icon
Intuitive Surgical
ISRG
+$23.5M
5
NTRA icon
Natera
NTRA
+$18M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$179B
$35.5M 6.28%
+289,312
BMY icon
2
Bristol-Myers Squibb
BMY
$123B
$34.9M 6.18%
+647,899
BSX icon
3
Boston Scientific
BSX
$106B
$34.4M 6.07%
360,428
+97,456
BBOT
4
BridgeBio Oncology
BBOT
$833M
$31.4M 5.55%
+410,700
LLY icon
5
Eli Lilly
LLY
$884B
$27.9M 4.92%
25,923
-31,453
DNTH icon
6
Dianthus Therapeutics
DNTH
$2.82B
$26.9M 4.76%
653,572
-14,043
ASND icon
7
Ascendis Pharma
ASND
$14.8B
$25.4M 4.5%
119,265
-25,689
SNDX icon
8
Syndax Pharmaceuticals
SNDX
$1.92B
$25.1M 4.44%
1,196,807
-417,910
JNJ icon
9
Johnson & Johnson
JNJ
$579B
$25M 4.42%
+120,840
REGN icon
10
Regeneron Pharmaceuticals
REGN
$80.3B
$23M 4.07%
29,797
-5,547
GPCR icon
11
Structure Therapeutics
GPCR
$4.08B
$17.6M 3.11%
252,901
-398,909
SLNO icon
12
Soleno Therapeutics
SLNO
$2.13B
$16.7M 2.95%
360,340
-57,905
CYTK icon
13
Cytokinetics
CYTK
$7.39B
$16.4M 2.9%
258,381
-193,200
EW icon
14
Edwards Lifesciences
EW
$47.4B
$15.9M 2.82%
+187,048
ISRG icon
15
Intuitive Surgical
ISRG
$174B
$15.4M 2.72%
27,209
-44,134
NTRA icon
16
Natera
NTRA
$27.6B
$14.3M 2.52%
62,273
-86,096
ADPT icon
17
Adaptive Biotechnologies
ADPT
$2.29B
$13.3M 2.36%
821,195
-63,695
ABVX
18
Abivax
ABVX
$8.65B
$13.3M 2.35%
98,514
-63,627
SUPN icon
19
Supernus Pharmaceuticals
SUPN
$3.1B
$12.8M 2.26%
257,465
-29,625
GUTS icon
20
Fractyl Health
GUTS
$73.6M
$12.1M 2.14%
5,491,866
+277,630
MLYS icon
21
Mineralys Therapeutics
MLYS
$2.1B
$12M 2.13%
+331,849
PHAT icon
22
Phathom Pharmaceuticals
PHAT
$841M
$11.6M 2.05%
698,996
-429,525
ADMA icon
23
ADMA Biologics
ADMA
$3.66B
$10.3M 1.82%
564,461
-120,047
ACLX icon
24
Arcellx
ACLX
$6.69B
$10.2M 1.8%
+156,109
DYN icon
25
Dyne Therapeutics
DYN
$2.45B
$10.2M 1.8%
+519,715
1
2 3